Literature DB >> 21093043

Protein adsorption and complement activation for di-block copolymer nanoparticles.

Christine Vauthier1, Bjorn Persson, Peter Lindner, Bernard Cabane.   

Abstract

Four types of nanoparticles with core-diffuse shell structures have been synthesized through self-assembly of PICBA-Dextran block copolymers. These nanoparticles are designed to carry pharmaceutically active molecules into the human body through injection into the blood stream. In this work, we have determined how the characteristics of the diffuse shell influence the adsorption of three types of proteins: Bovine Serum Albumin (BSA), fibrinogen, and a protein from the complement system that triggers recognition and elimination by macrophages. We have determined the structural characteristics of the diffuse shells using Nuclear Magnetic Resonance (NMR), Small Angle Neutron Scattering (SANS) and Quasi-Elastic Light Scattering (QELS). We have measured the adsorption of Bovine Serum Albumin (BSA) through Immunodiffusion methods, and found that it adsorbed in substantial amounts even when the distance between dextran chains at the core-diffuse shell interface is quite short. We have observed the aggregation of the nanoparticles induced by fibrinogen, and found that it was prevented when the density of dextran chains protruding from the core surface was sufficiently high. Finally we have measured the activation of the complement system by the nanoparticles, and found that it was also limited by the surface density of dextran chains that protrude from the core and by their mesh size within the diffuse shell. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21093043     DOI: 10.1016/j.biomaterials.2010.10.026

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  16 in total

1.  Effects of block copolymer properties on nanocarrier protection from in vivo clearance.

Authors:  Suzanne M D'Addio; Walid Saad; Steven M Ansell; John J Squiers; Douglas H Adamson; Margarita Herrera-Alonso; Adam R Wohl; Thomas R Hoye; Christopher W Macosko; Lawrence D Mayer; Christine Vauthier; Robert K Prud'homme
Journal:  J Control Release       Date:  2012-06-23       Impact factor: 9.776

2.  Multimodal Dispersion of Nanoparticles: A Comprehensive Evaluation of Size Distribution with 9 Size Measurement Methods.

Authors:  Fanny Varenne; Ali Makky; Mireille Gaucher-Delmas; Frédéric Violleau; Christine Vauthier
Journal:  Pharm Res       Date:  2016-02-10       Impact factor: 4.200

3.  Nanomedicine for gene therapy.

Authors:  Susan Muthe Alex; Chandra P Sharma
Journal:  Drug Deliv Transl Res       Date:  2013-10       Impact factor: 4.617

4.  Fibrinogen-templated gold nanoclusters for fluorometric determination of cysteine and mercury(II).

Authors:  Zhiguang Suo; Xialing Hou; Ziheng Hu; Yihao Liu; Feifei Xing; Lingyan Feng
Journal:  Mikrochim Acta       Date:  2019-11-18       Impact factor: 5.833

Review 5.  Application of polysaccharides for surface modification of nanomedicines.

Authors:  Kyung-Oh Doh; Yoon Yeo
Journal:  Ther Deliv       Date:  2012-12

6.  The nano-plasma interface: Implications of the protein corona.

Authors:  Joy Wolfram; Yong Yang; Jianliang Shen; Asad Moten; Chunying Chen; Haifa Shen; Mauro Ferrari; Yuliang Zhao
Journal:  Colloids Surf B Biointerfaces       Date:  2014-03-02       Impact factor: 5.268

7.  Materials design at the interface of nanoparticles and innate immunity.

Authors:  Gregory Lee Szeto; Erin B Lavik
Journal:  J Mater Chem B       Date:  2016-01-29       Impact factor: 6.331

Review 8.  Safety of Nanoparticles in Medicine.

Authors:  Joy Wolfram; Motao Zhu; Yong Yang; Jianliang Shen; Emanuela Gentile; Donatella Paolino; Massimo Fresta; Guangjun Nie; Chunying Chen; Haifa Shen; Mauro Ferrari; Yuliang Zhao
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

Review 9.  Nanoparticle characterization: state of the art, challenges, and emerging technologies.

Authors:  Eun Jung Cho; Hillary Holback; Karen C Liu; Sara A Abouelmagd; Joonyoung Park; Yoon Yeo
Journal:  Mol Pharm       Date:  2013-03-21       Impact factor: 4.939

10.  Engineering Intravenously Administered Nanoparticles to Reduce Infusion Reaction and Stop Bleeding in a Large Animal Model of Trauma.

Authors:  Chimdiya Onwukwe; Nuzhat Maisha; Mark Holland; Matt Varley; Rebecca Groynom; DaShawn Hickman; Nishant Uppal; Andrew Shoffstall; Jeffrey Ustin; Erin Lavik
Journal:  Bioconjug Chem       Date:  2018-07-09       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.